Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke
Go back to Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke| Abbott Laboratories (NYSE: ABT) | Delayed: 105.52 -2.81 (2.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.33 | 52 Week High | $46.38 | |||
| Open | $108.36 | 52 Week Low | $36.00 | |||
| Day High | $108.39 | P/E | 70.35 | |||
| Day Low | $105.24 | EPS | $1.50 | |||
| Volume | 11,250,390 | |||||
